Cardiac troponin in suspected ACS: From diagnosis to prognosis
3 Sept 2026This application note explores how cardiac troponin I testing with the Atellica® IM High-Sensitivity Troponin I (TnIH) Assay can provide insight beyond the diagnosis of acute myocardial infarction in patients with suspected acute coronary syndrome (ACS).
Discover how high-sensitivity cardiac troponin measurements can support risk stratification across the interconnected landscape of cardiovascular, kidney, and metabolic health. Clinical study data demonstrate the prognostic value of cardiac troponin I across different patient populations, helping clinicians identify increased risk and make more informed patient-management decisions.
Resource details:
Resource type: Application note
Page count: 5
Read time: 8 mins
Related products
Request Quote for All Products
Atellica® IM High-Sensitivity Troponin I (TnIH) Assay
Siemens HealthineersAtellica IM High-Sensitivity Troponin I assay is first in the US to include Prognostic Risk as part of a new, expanded intended use claim